Woodline Partners’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.72M | Sell |
2,348,526
-165,558
| -7% | -$192K | 0.01% | 674 |
|
|
2025
Q1 | $3.39M | Buy |
2,514,084
+2,386,789
| +1,875% | +$3.22M | 0.02% | 590 |
|
|
2024
Q4 | $1.68M | Buy |
127,295
+15,635
| +14% | +$206K | 0.01% | 684 |
|
|
2024
Q3 | $1.25M | Buy |
111,660
+8,037
| +8% | +$90.1K | 0.01% | 496 |
|
|
2024
Q2 | $1.11M | Buy |
103,623
+3,480
| +3% | +$37.4K | 0.01% | 451 |
|
|
2024
Q1 | $1.49M | Sell |
100,143
-23,947
| -19% | -$357K | 0.01% | 440 |
|
|
2023
Q4 | $2.25M | Sell |
124,090
-312,162
| -72% | -$5.65M | 0.02% | 369 |
|
|
2023
Q3 | $7.56M | Buy |
436,252
+178,754
| +69% | +$3.1M | 0.09% | 253 |
|
|
2023
Q2 | $4.67M | Buy |
+257,498
| New | +$4.67M | 0.06% | 300 |
|
|
2021
Q4 | – | Sell |
-179,993
| Closed | -$3.04M | – | 767 |
|
|
2021
Q3 | $3.04M | Buy |
179,993
+108,330
| +151% | +$1.83M | 0.05% | 334 |
|
|
2021
Q2 | $2.09M | Buy |
+71,663
| New | +$2.09M | 0.04% | 350 |
|
|
2020
Q4 | – | Sell |
-152,000
| Closed | -$3.44M | – | 260 |
|
|
2020
Q3 | $3.44M | Buy |
+152,000
| New | +$3.44M | 0.11% | 149 |
|